{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-036366","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.610165+00:00","generated_at":"2026-05-23T10:55:29.030252+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Traws Pharma finalizes interim CEO Iain Dukes' employment; Jack Stover named Chairman","bullets":["Employment agreement with Iain Dukes effective April 1, 2025: base salary $610K, target bonus 50% of base.","Term of one year, auto-renew; severance only after first anniversary unless change in control.","Dr. Dukes stepped down as Chairman on April 15, 2025; director Jack Stover appointed Chairman.","Dr. Dukes remains a board member after transitioning chairman role.","Agreement replaces April 2024 offer letter; details in Exhibit 10.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-036366","json":"https://secwatch.observer/filing/0001104659-25-036366.json","markdown":"https://secwatch.observer/filing/0001104659-25-036366.md","text":"https://secwatch.observer/filing/0001104659-25-036366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/0001104659-25-036366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925036366/tm2512673d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:55:29.030252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}